Evidence map›Paper›PMID 31466241›Full record

ArticleNanomaterials (Basel, Switzerland)2019

A DFT Approach to the Surface-Enhanced Raman Scattering of 4-Cyanopyridine Adsorbed on Silver Nanoparticles.

Isabel López-Tocón, Samuel Valdivia, Juan Soto, Juan Carlos Otero, Francesco Muniz-Miranda, Maria Cristina Menziani, Maurizio Muniz-Miranda

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Spectroscopic and Microscopic Analyses of FeNanomaterials (Basel, Switzerland) · 2020
    Article
  9. Article
  10. The role of AgBeilstein journal of nanotechnology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Isabel López-TocónAndalucía Tech, Unidad Asociada IEM-CSIC, Departamento de química Física, Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain. tocon@uma.es.
Samuel ValdiviaAndalucía Tech, Unidad Asociada IEM-CSIC, Departamento de química Física, Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain.ORCID 0000-0002-2752-976X
Juan SotoAndalucía Tech, Unidad Asociada IEM-CSIC, Departamento de química Física, Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain.ORCID 0000-0001-6702-2878
Juan Carlos OteroAndalucía Tech, Unidad Asociada IEM-CSIC, Departamento de química Física, Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain.
Francesco Muniz-MirandaPresent Address: Chimie ParisTech, PSL Research University, CNRS, Institute of Chemistry for Life and Health Sciences, F-75005 Paris, France.
Maria Cristina MenzianiDepartment of Chemical and Geological Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy.ORCID 0000-0003-3428-5297
Maurizio Muniz-MirandaDepartment of Chemistry "Ugo Schiff", University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, Italy.ORCID 0000-0001-9457-6833

Funding

Ministerio de Ciencia y Tecnología CTQ2015-65816-RMinistero dell'Istruzione, dell'Università e della Ricerca RBFR1248UI_002
6 · The paper itself

Abstract

A Surface-Enhanced Raman Scattering (SERS) spectrum of 4-cyanopyridine (4CNPy) was recorded on silver plasmonic nanoparticles and analyzed by using Density Functional Theory (DFT) calculations. Two simple molecular models of the metal-4CNPy surface complex with a single silver cation or with a neutral dimer (Ag

Indexed as

4-cyanopyridineDFT calculationsmetal nanoparticlesSERSsilver sol

Identifiers

PMID31466241
PMCPMC6780094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.